{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:40:01Z","timestamp":1789404001449,"version":"build-2803163510"},"reference-count":76,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,12,7]],"date-time":"2015-12-07T00:00:00Z","timestamp":1449446400000},"content-version":"vor","delay-in-days":1467,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1038\/ki.2011.261","type":"journal-article","created":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T12:47:10Z","timestamp":1312980430000},"page":"1198-1211","source":"Crossref","is-referenced-by-count":141,"title":["Chronic kidney disease worsens sepsis and sepsis-induced acute kidney injury by releasing High Mobility Group Box Protein-1"],"prefix":"10.1016","volume":"80","author":[{"given":"Asada","family":"Leelahavanichkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuning","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuzhen","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey B.","family":"Kopp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Schnermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter S.T.","family":"Yuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Star","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/ki.2011.261_bb0010","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1056\/NEJMoa022139","article-title":"The epidemiology of sepsis in the United States from 1979 through 2000","volume":"348","author":"Martin","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.261_bb0015","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1172\/JCI39421","article-title":"Animal models of sepsis and sepsis-induced kidney injury","volume":"119","author":"Doi","year":"2009","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"10.1038\/ki.2011.261_bb0020","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1097\/CCM.0b013e3181922bd3","article-title":"Animal models of sepsis: why does preclinical efficacy fail to translate to the clinical setting?","volume":"37","author":"Dyson","year":"2009","journal-title":"Crit Care Med"},{"issue":"Suppl 5","key":"10.1038\/ki.2011.261_bb0025","doi-asserted-by":"crossref","first-page":"S219","DOI":"10.1097\/01.CCM.0000127036.27343.48","article-title":"Why do animal models (sometimes) fail to mimic human sepsis?","volume":"32","author":"Esmon","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1038\/ki.2011.261_bb0030","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1172\/JCI200319523","article-title":"The enigma of sepsis","volume":"112","author":"Riedemann","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2011.261_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1189\/jlb.0806542","article-title":"The disconnect between animal models of sepsis and human sepsis","volume":"81","author":"Rittirsch","year":"2007","journal-title":"J Leukoc Biol"},{"key":"10.1038\/ki.2011.261_bb0040","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1097\/00003246-200107000-00002","article-title":"Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care","volume":"29","author":"Angus","year":"2001","journal-title":"Crit Care Med"},{"issue":"Suppl 7","key":"10.1038\/ki.2011.261_bb0045","doi-asserted-by":"crossref","first-page":"S481","DOI":"10.1086\/432001","article-title":"Underlying disorders and their impact on the host response to infection","volume":"41","author":"Dhainaut","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1038\/ki.2011.261_bb0050","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2215\/CJN.01290308","article-title":"Epidemiology of acute infections among patients with chronic kidney disease","volume":"3","author":"Dalrymple","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.261_bb0055","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ackd.2006.04.004","article-title":"Infectious complications in chronic kidney disease","volume":"13","author":"Naqvi","year":"2006","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1038\/ki.2011.261_bb0060","first-page":"S79","article-title":"Immune dysfunction in uremia","volume":"62","author":"Cohen","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2011.261_bb0065","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1525-139X.2007.00283.x","article-title":"Disturbances of acquired immunity in hemodialysis patients","volume":"20","author":"Eleftheriadis","year":"2007","journal-title":"Semin Dial"},{"key":"10.1038\/ki.2011.261_bb0070","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/sj.ki.5002425","article-title":"Uremia impairs monocyte and monocyte-derived dendritic cell function in hemodialysis patients","volume":"72","author":"Lim","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.261_bb0075","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0891-5520(05)70152-5","article-title":"Infections associated with uremia and dialysis","volume":"15","author":"Minnaganti","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1038\/ki.2011.261_bb0080","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0891-5520(05)70174-4","article-title":"Immunologic defects and vaccination in patients with chronic renal failure","volume":"15","author":"Pesanti","year":"2001","journal-title":"Infect Dis Clin North Am"},{"key":"10.1038\/ki.2011.261_bb0085","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1681\/ASN.V391541","article-title":"Infectious morbidity and defects of phagocytic function in end-stage renal disease: a review","volume":"3","author":"Vanholder","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.261_bb0090","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000126926","article-title":"Cytokine dysregulation in chronic kidney disease: how can we treat it?","volume":"26","author":"Carrero","year":"2008","journal-title":"Blood Purif"},{"key":"10.1038\/ki.2011.261_bb0095","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1046\/j.1523-1755.1999.00422.x","article-title":"Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure","volume":"55","author":"Stenvinkel","year":"1999","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.261_bb0100","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1111\/j.1523-1755.2005.00200.x","article-title":"IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia\u2014the good, the bad, and the ugly","volume":"67","author":"Stenvinkel","year":"2005","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.261_bb0105","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000067852","article-title":"Inflammation and atherosclerosis in end-stage renal disease","volume":"21","author":"Zoccali","year":"2003","journal-title":"Blood Purif"},{"key":"10.1038\/ki.2011.261_bb0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1164\/rccm.200208-785OC","article-title":"Influence of systemic inflammatory response syndrome and sepsis on outcome of critically ill infected patients","volume":"168","author":"Alberti","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1038\/ki.2011.261_bb0115","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/0003-4819-96-4-417","article-title":"Predicting survival in adults with end-stage renal disease: an age equivalence index","volume":"96","author":"Hutchinson","year":"1982","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.261_bb0120","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/ki.2008.346","article-title":"Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome","volume":"74","author":"Doi","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.261_bb0125","first-page":"87","article-title":"Folic acid-induced renal injury and repair. Correlation of structural and functional abnormalities","volume":"104","author":"Klingler","year":"1980","journal-title":"Arch Pathol Lab Med"},{"key":"10.1038\/ki.2011.261_bb0130","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/ki.2010.287","article-title":"Angiotensin II overcomes strain-dependent resistance of rapid CKD progression in a new remnant kidney mouse model","volume":"78","author":"Leelahavanichkul","year":"2010","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.261_bb0135","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2119\/2007-00107.Bruchfeld","article-title":"High Mobility Group Box Protein-1 correlates with renal function in chronic kidney disease (CKD)","volume":"14","author":"Bruchfeld","year":"2008","journal-title":"Mol Med"},{"key":"10.1038\/ki.2011.261_bb0140","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1084\/jem.20052203","article-title":"Role of HMGB1 in apoptosis-mediated sepsis lethality","volume":"203","author":"Qin","year":"2006","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2011.261_bb0145","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.285.5425.248","article-title":"HMG-1 as a late mediator of endotoxin lethality in mice","volume":"285","author":"Wang","year":"1999","journal-title":"Science"},{"key":"10.1038\/ki.2011.261_bb0150","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1073\/pnas.2434651100","article-title":"Reversing established sepsis with antagonists of endogenous high-mobility group box 1","volume":"101","author":"Yang","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/ki.2011.261_bb0155","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1097\/01.shk.0000190827.36406.6e","article-title":"Vascular endothelial growth factor is increased during the first 48 hours of human septic shock and correlates with vascular permeability","volume":"24","author":"Pickkers","year":"2005","journal-title":"Shock"},{"key":"10.1038\/ki.2011.261_bb0160","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.shk.0000150728.91155.41","article-title":"Plasma vascular endothelial growth factor in severe sepsis","volume":"23","author":"van der Flier","year":"2005","journal-title":"Shock"},{"key":"10.1038\/ki.2011.261_bb0165","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1084\/jem.20060375","article-title":"Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality","volume":"203","author":"Yano","year":"2006","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2011.261_bb0170","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/nri1943","article-title":"Apoptosis and caspases regulate death and inflammation in sepsis","volume":"6","author":"Hotchkiss","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/ki.2011.261_bb0175","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000049071","article-title":"Elevated plasma vascular endothelial growth factor levels in non-diabetic predialysis uraemia","volume":"90","author":"Harper","year":"2002","journal-title":"Nephron"},{"key":"10.1038\/ki.2011.261_bb0180","first-page":"CR181","article-title":"Possible association between circulating vascular endothelial growth factor and oxidative stress markers in hemodialysis patients","volume":"12","author":"Pawlak","year":"2006","journal-title":"Med Sci Monit"},{"key":"10.1038\/ki.2011.261_bb0185","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.4049\/jimmunol.181.5.3535","article-title":"Splenectomy protects against sepsis lethality and reduces serum HMGB1 levels","volume":"181","author":"Huston","year":"2008","journal-title":"J Immunol"},{"key":"10.1038\/ki.2011.261_bb0190","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1097\/01.CCM.0000275273.56547.B8","article-title":"Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis","volume":"35","author":"Tsao","year":"2007","journal-title":"Crit Care Med"},{"key":"10.1038\/ki.2011.261_bb0195","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.molmed.2004.12.007","article-title":"The \u2018cytokine profile\u2019: a code for sepsis","volume":"11","author":"Ulloa","year":"2005","journal-title":"Trends Mol Med"},{"key":"10.1038\/ki.2011.261_bb0200","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1159\/000095588","article-title":"Comparison of experimental lung injury from acute renal failure with injury due to sepsis","volume":"73","author":"Kim do","year":"2006","journal-title":"Respiration"},{"key":"10.1038\/ki.2011.261_bb0205","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0940-2993(11)80347-7","article-title":"Increased sensitivity to bilateral nephrectomy in rat caused by endotoxemia","volume":"47","author":"Zurovsky","year":"1995","journal-title":"Exp Toxicol Pathol"},{"key":"10.1038\/ki.2011.261_bb0210","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/nm0603-669","article-title":"The biology of VEGF and its receptors","volume":"9","author":"Ferrara","year":"2003","journal-title":"Nat Med"},{"key":"10.1038\/ki.2011.261_bb0215","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5414\/CNP70091","article-title":"Protein catabolism in advanced renal disease: role of cytokines","volume":"70","author":"Fleet","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1038\/ki.2011.261_bb0220","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-119-8-199310150-00001","article-title":"Plasma cytokine and endotoxin levels correlate with survival in patients with the sepsis syndrome","volume":"119","author":"Casey","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1038\/ki.2011.261_bb0225","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/bja\/77.1.110","article-title":"Sepsis and cytokines: current status","volume":"77","author":"Blackwell","year":"1996","journal-title":"Br J Anaesth"},{"key":"10.1038\/ki.2011.261_bb0230","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1172\/JCI115298","article-title":"Treatment with recombinant human tumor necrosis factor-alpha protects rats against the lethality, hypotension, and hypothermia of gram-negative sepsis","volume":"88","author":"Alexander","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1038\/ki.2011.261_bb0235","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1046\/j.1523-1755.1998.00981.x","article-title":"Immunologic function and survival in hemodialysis patients","volume":"54","author":"Kimmel","year":"1998","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.261_bb0240","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1046\/j.1523-1755.2000.07613.x","article-title":"Clinical relevance of cytokine production in hemodialysis","volume":"76","author":"Pertosa","year":"2000","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2011.261_bb0245","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0928-4257(00)00146-7","article-title":"Growth factors in ulcer healing: lessons from recent studies","volume":"94","author":"Szabo","year":"2000","journal-title":"J Physiol Paris"},{"key":"10.1038\/ki.2011.261_bb0250","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1524-475X.2008.00410.x","article-title":"Growth factors and cytokines in wound healing","volume":"16","author":"Barrientos","year":"2008","journal-title":"Wound Repair Regen"},{"key":"10.1038\/ki.2011.261_bb0255","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nature00858","article-title":"Release of chromatin protein HMGB1 by necrotic cells triggers inflammation","volume":"418","author":"Scaffidi","year":"2002","journal-title":"Nature"},{"key":"10.1038\/ki.2011.261_bb0260","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1084\/jem.192.4.565","article-title":"High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes","volume":"192","author":"Andersson","year":"2000","journal-title":"J Exp Med"},{"key":"10.1038\/ki.2011.261_bb0265","doi-asserted-by":"crossref","first-page":"5551","DOI":"10.1093\/emboj\/cdg516","article-title":"Monocytic cells hyperacetylate chromatin protein HMGB1 to redirect it towards secretion","volume":"22","author":"Bonaldi","year":"2003","journal-title":"EMBO J"},{"key":"10.1038\/ki.2011.261_bb0270","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/BF03402105","article-title":"Structural basis for the proinflammatory cytokine activity of high mobility group box 1","volume":"9","author":"Li","year":"2003","journal-title":"Mol Med"},{"key":"10.1038\/ki.2011.261_bb0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.1104648","article-title":"The cytokine activity of HMGB1","volume":"78","author":"Yang","year":"2005","journal-title":"J Leukoc Biol"},{"key":"10.1038\/ki.2011.261_bb0280","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1365-2796.2003.01302.x","article-title":"Extracellular role of HMGB1 in inflammation and sepsis","volume":"255","author":"Wang","year":"2004","journal-title":"J Intern Med"},{"key":"10.1038\/ki.2011.261_bb0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/SHK.0b013e3181997173","article-title":"HMGB1 is markedly elevated within 6 hours of mechanical trauma in humans","volume":"32","author":"Peltz","year":"2009","journal-title":"Shock"},{"key":"10.1038\/ki.2011.261_bb0290","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.4049\/jimmunol.0902660","article-title":"The alarmin cytokine, high mobility group box 1, is produced by viable cardiomyocytes and mediates the lipopolysaccharide-induced myocardial dysfunction via a TLR4\/phosphatidylinositol 3-kinase gamma pathway","volume":"184","author":"Xu","year":"2010","journal-title":"J Immunol"},{"key":"10.1038\/ki.2011.261_bb0295","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.4049\/jimmunol.178.6.3856","article-title":"A cardiovascular drug rescues mice from lethal sepsis by selectively attenuating a late-acting proinflammatory mediator, high mobility group box 1","volume":"178","author":"Li","year":"2007","journal-title":"J Immunol"},{"key":"10.1038\/ki.2011.261_bb0300","doi-asserted-by":"crossref","first-page":"H1490","DOI":"10.1152\/ajpheart.00910.2007","article-title":"Negative inotropic effects of high-mobility group box 1 protein in isolated contracting cardiac myocytes","volume":"294","author":"Tzeng","year":"2008","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1038\/ki.2011.261_bb0305","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1056\/NEJMra021333","article-title":"The pathophysiology and treatment of sepsis","volume":"348","author":"Hotchkiss","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1038\/ki.2011.261_bb0310","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1681\/ASN.V10193","article-title":"Neutrophil apoptosis and dysfunction in uremia","volume":"10","author":"Cendoroglo","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.261_bb0315","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ki.1996.110","article-title":"Apoptosis of monocytes cultured from long-term hemodialysis patients","volume":"49","author":"Heidenreich","year":"1996","journal-title":"Kidney Int"},{"key":"10.1038\/ki.2011.261_bb0320","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1046\/j.1523-1755.2001.59780197.x","article-title":"Apoptosis of leukocytes: basic concepts and implications in uremia","volume":"78","author":"Jaber","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1038\/ki.2011.261_bb0325","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1006\/bbrc.1995.2438","article-title":"Relationship between susceptibility to apoptosis and Fas expression in peripheral blood T cells from uremic patients: a possible mechanism for lymphopenia in chronic renal failure","volume":"215","author":"Matsumoto","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1038\/ki.2011.261_bb0330","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1067\/mlc.2000.109318","article-title":"Serum soluble Fas (CD95) and Fas ligand profiles in chronic kidney failure","volume":"136","author":"Perianayagam","year":"2000","journal-title":"J Lab Clin Med"},{"key":"10.1038\/ki.2011.261_bb0335","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/153968503768330256","article-title":"Immune traffic: a functional overview","volume":"1","author":"Beilhack","year":"2003","journal-title":"Lymphat Res Biol"},{"key":"10.1038\/ki.2011.261_bb0340","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.2174\/1381612033454306","article-title":"The immunocompromised host: immune alterations in splenectomized patients and clinical implications","volume":"9","author":"Jirillo","year":"2003","journal-title":"Curr Pharm Des"},{"key":"10.1038\/ki.2011.261_bb0345","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/0923-2494(91)90081-S","article-title":"The human spleen and the immune system: not just another lymphoid organ","volume":"142","author":"Timens","year":"1991","journal-title":"Res Immunol"},{"key":"10.1038\/ki.2011.261_bb0350","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1681\/ASN.2008060617","article-title":"Reduced production of creatinine limits its use as marker of kidney injury in sepsis","volume":"20","author":"Doi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/ki.2011.261_bb0355","doi-asserted-by":"crossref","first-page":"F1825","DOI":"10.1152\/ajprenal.90442.2008","article-title":"Methyl-2-acetamidoacrylate, an ethyl pyruvate analog, decreases sepsis-induced acute kidney injury in mice","volume":"295","author":"Leelahavanichkul","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2011.261_bb0360","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cca.2006.07.019","article-title":"HMGB1, a novel inflammatory cytokine","volume":"375","author":"Yamada","year":"2007","journal-title":"Clin Chim Acta"},{"key":"10.1038\/ki.2011.261_bb0365","doi-asserted-by":"crossref","first-page":"F1116","DOI":"10.1152\/ajprenal.00366.2003","article-title":"A simplified method for HPLC determination of creatinine in mouse serum","volume":"286","author":"Yuen","year":"2004","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/ki.2011.261_bb0370","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1023\/A:1016079228995","article-title":"Serial vs. sparse sampling in toxicokinetic studies","volume":"13","author":"Tse","year":"1996","journal-title":"Pharm Res"},{"key":"10.1038\/ki.2011.261_bb0375","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0378-4274(88)90024-0","article-title":"Cisplatin pharmacokinetics: applications of a physiological model","volume":"43","author":"Farris","year":"1988","journal-title":"Toxicol Lett"},{"issue":"Suppl 4","key":"10.1038\/ki.2011.261_bb0380","first-page":"S157","article-title":"Pharmacokinetics of sirolimus in Thai healthy volunteers","volume":"88","author":"Leelahavanichkul","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"10.1038\/ki.2011.261_bb0385","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/ki.2008.97","article-title":"AP214, an analogue of alpha-melanocyte-stimulating hormone, ameliorates sepsis-induced acute kidney injury and mortality","volume":"73","author":"Doi","year":"2008","journal-title":"Kidney Int"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815549740?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253815549740?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T04:00:49Z","timestamp":1638244849000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253815549740"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0085253815549740"],"URL":"https:\/\/doi.org\/10.1038\/ki.2011.261","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]}}}